vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and Sylvamo Corp (SLVM). Click either name above to swap in a different company.

ILLUMINA, INC. is the larger business by last-quarter revenue ($1.1B vs $890.0M, roughly 1.2× Sylvamo Corp). ILLUMINA, INC. runs the higher net margin — 12.3% vs 3.7%, a 8.6% gap on every dollar of revenue. On growth, ILLUMINA, INC. posted the faster year-over-year revenue change (4.8% vs -8.2%). ILLUMINA, INC. produced more free cash flow last quarter ($251.0M vs $38.0M). Over the past eight quarters, Sylvamo Corp's revenue compounded faster (-0.8% CAGR vs -1.3%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

Sylvamo Corp is a leading global manufacturer of sustainable paper and pulp products. Its core offerings include uncoated printing paper, packaging paper, and market pulp, serving office supplies, publishing, commercial printing, and packaging segments across North America, Europe, and Latin America.

ILMN vs SLVM — Head-to-Head

Bigger by revenue
ILMN
ILMN
1.2× larger
ILMN
$1.1B
$890.0M
SLVM
Growing faster (revenue YoY)
ILMN
ILMN
+13.1% gap
ILMN
4.8%
-8.2%
SLVM
Higher net margin
ILMN
ILMN
8.6% more per $
ILMN
12.3%
3.7%
SLVM
More free cash flow
ILMN
ILMN
$213.0M more FCF
ILMN
$251.0M
$38.0M
SLVM
Faster 2-yr revenue CAGR
SLVM
SLVM
Annualised
SLVM
-0.8%
-1.3%
ILMN

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
ILMN
ILMN
SLVM
SLVM
Revenue
$1.1B
$890.0M
Net Profit
$134.0M
$33.0M
Gross Margin
66.1%
Operating Margin
19.2%
8.9%
Net Margin
12.3%
3.7%
Revenue YoY
4.8%
-8.2%
Net Profit YoY
-59.3%
EPS (diluted)
$0.87
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
SLVM
SLVM
Q1 26
$1.1B
Q4 25
$1.2B
$890.0M
Q3 25
$846.0M
Q2 25
$794.0M
Q1 25
$821.0M
Q4 24
$1.1B
$970.0M
Q3 24
$1.1B
$965.0M
Q2 24
$1.1B
$933.0M
Net Profit
ILMN
ILMN
SLVM
SLVM
Q1 26
$134.0M
Q4 25
$334.0M
$33.0M
Q3 25
$57.0M
Q2 25
$15.0M
Q1 25
$27.0M
Q4 24
$186.0M
$81.0M
Q3 24
$705.0M
$95.0M
Q2 24
$-2.0B
$83.0M
Gross Margin
ILMN
ILMN
SLVM
SLVM
Q1 26
66.1%
Q4 25
65.5%
Q3 25
Q2 25
Q1 25
Q4 24
65.9%
Q3 24
69.0%
Q2 24
64.8%
Operating Margin
ILMN
ILMN
SLVM
SLVM
Q1 26
19.2%
Q4 25
17.4%
8.9%
Q3 25
11.6%
Q2 25
3.8%
Q1 25
5.4%
Q4 24
15.8%
11.2%
Q3 24
68.6%
15.5%
Q2 24
-147.2%
13.1%
Net Margin
ILMN
ILMN
SLVM
SLVM
Q1 26
12.3%
Q4 25
28.8%
3.7%
Q3 25
6.7%
Q2 25
1.9%
Q1 25
3.3%
Q4 24
16.8%
8.4%
Q3 24
65.3%
9.8%
Q2 24
-178.8%
8.9%
EPS (diluted)
ILMN
ILMN
SLVM
SLVM
Q1 26
$0.87
Q4 25
$2.16
$0.81
Q3 25
$1.41
Q2 25
$0.37
Q1 25
$0.65
Q4 24
$1.16
$1.91
Q3 24
$4.42
$2.27
Q2 24
$-12.48
$1.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
SLVM
SLVM
Cash + ST InvestmentsLiquidity on hand
$1.2B
$198.0M
Total DebtLower is stronger
$763.0M
Stockholders' EquityBook value
$2.7B
$966.0M
Total Assets
$6.6B
$2.8B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
SLVM
SLVM
Q1 26
$1.2B
Q4 25
$1.6B
$198.0M
Q3 25
$146.0M
Q2 25
$183.0M
Q1 25
$220.0M
Q4 24
$93.0M
$309.0M
Q3 24
$70.0M
$414.0M
Q2 24
$74.0M
$213.0M
Total Debt
ILMN
ILMN
SLVM
SLVM
Q1 26
Q4 25
$763.0M
Q3 25
$778.0M
Q2 25
$767.0M
Q1 25
$794.0M
Q4 24
$782.0M
Q3 24
$883.0M
Q2 24
$894.0M
Stockholders' Equity
ILMN
ILMN
SLVM
SLVM
Q1 26
$2.7B
Q4 25
$2.7B
$966.0M
Q3 25
$977.0M
Q2 25
$959.0M
Q1 25
$908.0M
Q4 24
$2.4B
$847.0M
Q3 24
$2.1B
$937.0M
Q2 24
$1.4B
$830.0M
Total Assets
ILMN
ILMN
SLVM
SLVM
Q1 26
$6.6B
Q4 25
$6.6B
$2.8B
Q3 25
$2.7B
Q2 25
$2.7B
Q1 25
$2.6B
Q4 24
$6.3B
$2.6B
Q3 24
$6.0B
$2.9B
Q2 24
$6.1B
$2.7B
Debt / Equity
ILMN
ILMN
SLVM
SLVM
Q1 26
Q4 25
0.79×
Q3 25
0.80×
Q2 25
0.80×
Q1 25
0.87×
Q4 24
0.92×
Q3 24
0.94×
Q2 24
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
SLVM
SLVM
Operating Cash FlowLast quarter
$289.0M
$94.0M
Free Cash FlowOCF − Capex
$251.0M
$38.0M
FCF MarginFCF / Revenue
23.0%
4.3%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
2.16×
2.85×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$44.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
SLVM
SLVM
Q1 26
$289.0M
Q4 25
$321.0M
$94.0M
Q3 25
$87.0M
Q2 25
$64.0M
Q1 25
$23.0M
Q4 24
$364.0M
$164.0M
Q3 24
$316.0M
$163.0M
Q2 24
$80.0M
$115.0M
Free Cash Flow
ILMN
ILMN
SLVM
SLVM
Q1 26
$251.0M
Q4 25
$267.0M
$38.0M
Q3 25
$33.0M
Q2 25
$-2.0M
Q1 25
$-25.0M
Q4 24
$335.0M
$100.0M
Q3 24
$284.0M
$119.0M
Q2 24
$49.0M
$62.0M
FCF Margin
ILMN
ILMN
SLVM
SLVM
Q1 26
23.0%
Q4 25
23.0%
4.3%
Q3 25
3.9%
Q2 25
-0.3%
Q1 25
-3.0%
Q4 24
30.3%
10.3%
Q3 24
26.3%
12.3%
Q2 24
4.4%
6.6%
Capex Intensity
ILMN
ILMN
SLVM
SLVM
Q1 26
Q4 25
6.3%
Q3 25
6.4%
Q2 25
8.3%
Q1 25
5.8%
Q4 24
2.6%
6.6%
Q3 24
3.0%
4.6%
Q2 24
2.8%
5.7%
Cash Conversion
ILMN
ILMN
SLVM
SLVM
Q1 26
2.16×
Q4 25
0.96×
2.85×
Q3 25
1.53×
Q2 25
4.27×
Q1 25
0.85×
Q4 24
1.96×
2.02×
Q3 24
0.45×
1.72×
Q2 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

SLVM
SLVM

Segment breakdown not available.

Related Comparisons